CNS Drug Development Expertise to Meet Critical Unmet Need

Therapeutic Depth:CNS

The central nervous system is complex; though CNS diseases can impact patients of all ages, they are set to rise as elderly populations double between 2011 and 20501. Drug development across the spectrum of CNS disorders requires specialized understanding and experience. At SynteractHCR, our knowledgeable project teams, therapeutic experts and access to top investigative sites can help you develop the best strategies to conduct CNS studies and focus on what matters most: developing treatments to improve and save the lives of patients.

SynteractHCR has the expertise to deliver full scope CNS clinical development programs, a la carte services or rescue failing trials with a reliable, experienced expansion of your in-house team.

SynteractHCR CNS expertise includes:


  • ALS
  • Alzheimer's Disease
  • Behavioral Variant Frontotemporal Dementia
  • Cervical Dystonia
  • Diabetic Neuropathy
  • Multiple Sclerosis
  • Parkinson's Disease
  • Restless Leg Syndrome


  • Chronic
  • Migraine
  • Neuropathic
  • Opioid Abuse
  • Postherpetic Neuralgia
  • Post Operative (including NDA)


  • ADHD
  • Alcohol Addiction
  • Anxiety
  • Compulsive Gambling
  • Depressive Disorder
  • Insomnia
  • Schizophrenia
  • Smoking Cessation
  • Sleep Disorders

Related Links

Well-rounded experience.

SynteractHCR has conducted
trials across all major
therapeutic areas and
we have contributed 
to more than 230
product approvals
since our
Learn More

Contact SynteractHCR

  • USA: +1 760 268 8200
  • Europe: +49 89 12 66 80 0
  • Contact Form...

Contact SynteractHCR

Tell us how to stay in touch with you:

Required Fields(*)